Will 2017 be the year when genomic medicine becomes business as usual?
There was no shortage of excitement (some might call it hype) about genomics and personalised healthcare in 2016, but for the vast majority of patients, the benefits of genomics remained tantalizingly out of reach. I have been wondering whether there are reasons to be more optimistic for 2017? Could this be the year that ‘patient […]
Read more "Will 2017 be the year when genomic medicine becomes business as usual?"